COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,496 Articles (22,363 medRxiv, 8,133 bioRxiv)

Most recent first Previous |  Page 204: Articles 2031-2040  | Next

Lethal Infection of Human ACE2-Transgenic Mice Caused by SARS-CoV-2-related Pangolin Coronavirus GX_P2V(short_3UTR)
Wei, L., Liu, S., Lu, S., Luo, S., An, X., Fan, H., Chen, W., Li, E., Tong, Y., Song, L.
10.1101/2024.01.03.574008 — Posted: 2024-01-04
A Murine Model of Post-acute Neurological Sequelae Following SARS-CoV-2 Variant Infection
Singh, A., Adam, A., Aditi, A., Peng, B.-H., Yu, X., Zou, J., Kulkarni, V. V., Kan, P., Jiang, W., Shi, P.-Y., Samir, P., Cisneros, I., Wang, T.
10.1101/2024.01.03.574064 — Posted: 2024-01-04
Prototype mRNA vaccines imprint broadly neutralizing human serum antibodies after Omicron variant-matched boosting
Liang, C.-Y., Raju, S., Liu, Z., Li, Y., Arunkumar, G. A., Case, J. B., Zost, S. J., Acreman, C. M., Carvalho dos Anjos, D. C., McLellan, J. S., Crowe, J. E., Whelan, S. P. J., Elbashir, S. M., Edwards, D. K., Diamond, M. S.
10.1101/2024.01.03.574018 — Posted: 2024-01-04
Quantifying the impact of social activities on SARS-CoV-2 transmission using Google mobility reports
Günther, F., Brustad, H. K., Frigessi, A., Britton, T.
10.1101/2024.01.03.24300755 — Posted: 2024-01-04
Shayona@SMM4H-23: COVID-19 Self diagnosis classification using BERT and LightGBM models
Chavda, R., Makwana, D., Patel, V., Shukla, A.
10.1101/2024.01.04.24300818 — Posted: 2024-01-04
Escalating combinations of enhanced infectivity and immune escape define SARS-CoV-2 Omicron lineage replacement
Chen, N. F. G., Pham, K., Chaguza, C., Lopes, R., Klaassen, F., Weinberger, D. M., Pitzer, V. E., Warren, J. L., Grubaugh, N. D., Hahn, A. M.
10.1101/2024.01.03.24300790 — Posted: 2024-01-04
Barriers to healthcare access: findings from a co-produced Long Covid case-finding study
Clutterbuck, D., Ramasawmy, M., Pantelic, M., Hayer, J., Begum, F., Faghy, M., Nasir, N., Causer, B., Heightman, M., Allsopp, G., Wootton, D., Khan, M. A., Hastie, C., Jackson, M., Rayner, C., Brown, D., Parrett, E., Jones, G., Clarke, R., Mcfarland, S., Gabbay, M., Banerjee, A., Alwan, N. A., STIMULATE-ICP Consortium
10.1101/2024.01.03.24300767 — Posted: 2024-01-04
The Struggle to Vaccinate: Unveiling the Reality of the first year of Covid-19 Vaccination in the Democratic Republic of Congo
Amani, A., Cikomola Mwana Bene, A., Luhata Lungoyo, C., Kabwaya Mukoka, A., Lekeumo Cheuyem, F. Z., Mpinganjira, S., Sibongile Nkosi, D., Chido Konono, K. C., Ngigi, M., Ongolo-Zogo, P.
10.1101/2024.01.03.24300795 — Posted: 2024-01-04
Artificial Intelligence (AI) Based Prediction of Mortality, ICU Admission and Ventilation Support Requirement for COVID-19 Patients Using 122 Clinical and Demographic Parameters
Tamal, M., Rahman, M. M., Alhashim, M., Al Mulhim, M., Deriche, M.
10.1101/2024.01.03.24300797 — Posted: 2024-01-04
Trends in SARS-CoV-2 seroprevalence among pregnant women attending first antenatal care visits in Zambia: a repeated cross-sectional survey, 2021-2022
Heilmann, E., Tembo, T., Fwoloshi, S., Kabamba, B., Chilambe, F., Kalenga, K., Siwingwa, M., Mulube, C., Seffren, V., Bolton-Moore, C., Simwanza, J., Yingst, S., Yadav, R., Rogier, E., Auld, A. F., Agolory, S., Kapina, M., Gutman, J. R., Savory, T., Kangale, C., Mulenga, L. B., Sikazwe, I., Hines, J. Z.
10.1101/2024.01.02.24300729 — Posted: 2024-01-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).